85 related articles for article (PubMed ID: 27441754)
21. Evaluation of available data sources to prioritize parishes for arsenic monitoring and outreach related to private well drinking water.
Katner A; Lackovic M; Streva K; Paul V; Trachtman WC
J Public Health Manag Pract; 2015; 21 Suppl 2():S93-101. PubMed ID: 25621453
[TBL] [Abstract][Full Text] [Related]
22. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
Mink PJ; Alexander DD; Barraj LM; Kelsh MA; Tsuji JS
Regul Toxicol Pharmacol; 2008 Dec; 52(3):299-310. PubMed ID: 18783726
[TBL] [Abstract][Full Text] [Related]
23. Geostatistical modelling of arsenic in drinking water wells and related toenail arsenic concentrations across Nova Scotia, Canada.
Dummer TJ; Yu ZM; Nauta L; Murimboh JD; Parker L
Sci Total Environ; 2015 Feb; 505():1248-58. PubMed ID: 24613511
[TBL] [Abstract][Full Text] [Related]
24. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
Marsit CJ; Karagas MR; Danaee H; Liu M; Andrew A; Schned A; Nelson HH; Kelsey KT
Carcinogenesis; 2006 Jan; 27(1):112-6. PubMed ID: 15987713
[TBL] [Abstract][Full Text] [Related]
25. Use of mode of action data to inform a dose-response assessment for bladder cancer following exposure to inorganic arsenic.
Gentry PR; Yager JW; Clewell RA; Clewell HJ
Toxicol In Vitro; 2014 Oct; 28(7):1196-205. PubMed ID: 24937311
[TBL] [Abstract][Full Text] [Related]
26. Nitrate and drinking water from private wells: will there be an epidemic of cancers of the digestive tract, urinary bladder and thyroid?
Njeze GE; Dilibe U; Ilo C
Niger J Clin Pract; 2014; 17(2):178-82. PubMed ID: 24553028
[TBL] [Abstract][Full Text] [Related]
27. Arsenic in drinking water and bladder cancer.
Steinmaus C; Moore L; Hopenhayn-Rich C; Biggs ML; Smith AH
Cancer Invest; 2000; 18(2):174-82. PubMed ID: 10705880
[No Abstract] [Full Text] [Related]
28. Evaluation of the carcinogenicity of inorganic arsenic.
Cohen SM; Arnold LL; Beck BD; Lewis AS; Eldan M
Crit Rev Toxicol; 2013 Oct; 43(9):711-52. PubMed ID: 24040994
[TBL] [Abstract][Full Text] [Related]
29. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water.
Andrew AS; Karagas MR; Hamilton JW
Int J Cancer; 2003 Apr; 104(3):263-8. PubMed ID: 12569548
[TBL] [Abstract][Full Text] [Related]
30. Low-dose risk assessment for arsenic: a meta-analysis approach.
Begum M; Horowitz J; Hossain MI
Asia Pac J Public Health; 2015 Mar; 27(2):NP20-35. PubMed ID: 23188879
[TBL] [Abstract][Full Text] [Related]
31. [Induction of urothelial carcinoma due to chronic arsenic ingestion? A occupational medicine-toxicological excursion].
Müller M; Böcher A; Buchter A
Urologe A; 2007 May; 46(5):511-2, 514-5. PubMed ID: 17216513
[TBL] [Abstract][Full Text] [Related]
32. A spatial study of bladder cancer mortality and incidence in the contiguous US: 2000-2014.
Amin RW; Stafford B; Guttmann RP
Sci Total Environ; 2019 Jun; 670():806-813. PubMed ID: 30921714
[TBL] [Abstract][Full Text] [Related]
33. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
[TBL] [Abstract][Full Text] [Related]
34. High bladder cancer mortality in rural New England (United States): an etiologic study.
Brown LM; Zahm SH; Hoover RN; Fraumeni JF
Cancer Causes Control; 1995 Jul; 6(4):361-8. PubMed ID: 7548724
[TBL] [Abstract][Full Text] [Related]
35. Cancer incidence and pattern of arsenic concentration in drinking water wells in Córdoba, Argentina.
Aballay LR; Díaz Mdel P; Francisca FM; Muñoz SE
Int J Environ Health Res; 2012; 22(3):220-31. PubMed ID: 22017596
[TBL] [Abstract][Full Text] [Related]
36. Private drinking water quality in rural Wisconsin.
Knobeloch L; Gorski P; Christenson M; Anderson H
J Environ Health; 2013 Mar; 75(7):16-20. PubMed ID: 23505770
[TBL] [Abstract][Full Text] [Related]
37. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
[TBL] [Abstract][Full Text] [Related]
38. Inorganic arsenic in drinking water: an evolving public health concern.
Lubin JH; Beane Freeman LE; Cantor KP
J Natl Cancer Inst; 2007 Jun; 99(12):906-7. PubMed ID: 17565151
[No Abstract] [Full Text] [Related]
39. Arsenic in drinking water.
Ahsan H
Kaohsiung J Med Sci; 2011 Sep; 27(9):358-9. PubMed ID: 21914521
[No Abstract] [Full Text] [Related]
40. Rationale for selecting exfoliated bladder cell micronuclei as potential biomarkers for arsenic genotoxicity.
Smith AH; Hopenhayn-Rich C; Warner M; Biggs ML; Moore L; Smith MT
J Toxicol Environ Health; 1993; 40(2-3):223-34. PubMed ID: 8230298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
